Thursday 29th November 2012
|Text too small?|
Tower, the insurer that's 34 percent owned by Guinness Peat Group, posted a 67 percent jump in full-year profit and said it will return $120 million to shareholders after the sale of medical insurance business. The shares climbed 4.2 percent as the market opened.
Profit rose to $55.8 million in the 12 months ended Sept. 30, from $33.4 million a year earlier, the Auckland-based company said in a statement. Revenue from ordinary activities rose 23 percent to $483 million.
Profit is within the guidance of $51 million to $56 million given by managing director Rob Flannagan on Nov. 2 when he announced the sales of Tower Medical Insurance to ASX-listed nib holdings for about $102 million. Profit tumbled in the previous year on costs of the Christchurch earthquakes and reduced revenue from investments.
"The result reflects improved performance across all business units, compared with the same period last year," Flannagan said. "The group is recovering well from the Canterbury earthquakes."
Tower will pay a final dividend of 6 cents a share, bringing payments for the year to 11 cents, up from a total of 6 cents last year. The shares rose 8 cents to $1.98 and have gained 25 percent this year. The stock is rated a 'hold' based on a Reuters poll of three analysts, with a median price target of $1.955.
The capital return means Guinness Peat, which is selling down its portfolio of assets, will get some $40.8 million. GPG shares rose 0.9 percent to 59 cents and are little changed this year.
Profit in the latest year includes a $9 million gain from the discount rate used when valuing life risk policy liabilities.
Total net premium revenue rose to $272 million from $235 million, led by a 15 percent increase in general insurance premiums to $238.9 million and a 5.9 percent increase in life premiums to $94.2 million.
Investment revenue surged 86 percent to $118.9 million, driven by a gain from equity securities and 'other' which includes derivative financial assets and liabilities. Property and fixed income both record declines.
Revenue from investment and management fees fell to $31.4 million from $33.8 million.
The $120 million capital return will use the sale proceeds and existing surplus capital and is likely to be via a scheme of arrangement, the company said today.
No comments yet
Tower to return 'initial' $70M of capital from sale of life business
Tower shares fall to 2-month low as licensing requirements may weigh on capital returns
Tower's licensing talks with RBNZ may push up minimum solvency requirements
Tower names Hancock as new chief executive, replacing Flannagan
Tower posts first-half profit as asset sales reap gains of $51.4 mln
Fidelity Life acquires most of Tower's life insurance business
Flannagan to leave Tower after strategic review, asset sales
Tower sells medical insurance unit to nib for $102M
Stiassny joins Tower board as questions linger over strategy
Tower lifts premiums for house, contents and motor cover